[1]冯颖青.β受体阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,(6):665-668.[doi:10.3969/j.issn.1004-3934.2015.06.003]
 FENG Yingqing.Role of Beta-blocker in Antihypertensive Treatment[J].Advances in Cardiovascular Diseases,2015,(6):665-668.[doi:10.3969/j.issn.1004-3934.2015.06.003]
点击复制

β受体阻滞剂在降压治疗中的应用()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2015年6期
页码:
665-668
栏目:
主题综述
出版日期:
2016-06-20

文章信息/Info

Title:
Role of Beta-blocker in Antihypertensive Treatment
作者:
冯颖青
广东省人民医院,广东 广州 510100
Author(s):
FENG Yingqing
Guangdong General Hospital,Guangzhou 510100,Guangdong,China
关键词:
β受体阻滞剂 高血压 治疗β
Keywords:
beta blockers hypertension treatment
分类号:
R972.+4; R544.1
DOI:
10.3969/j.issn.1004-3934.2015.06.003
文献标志码:
A
摘要:
β肾上腺素能受体阻滞剂(β受体阻滞剂)是常用的降压药物之一,近年来多项研究均对β受体阻滞剂的一线降压地位提出质疑,不同的高血压指南对β受体阻滞剂的推荐不一致。β受体阻滞剂在高血压治疗中的地位如何?β受体阻滞剂适用于哪些高血压患者?在临床使用中应注意什么事项?
Abstract:
adrenergic receptor blockers(beta blockers)are one of the most commonly used antihypertensive drugs. In recent years, a number of studies have recommended that beta blockers are no longer used as first-line therapy for hypertension without comorbidities. The recommendation of beta blockers in different guidelines for hypertension are different.What is the role of beta blockers in the treatment of hypertension what should we pay attention to in clinical treatment?

参考文献/References:

[1] James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee(JNC 8)[J]. JAMA,2014,311(5):507-520.
[2] Shimamoto K, Ando K, Fujita T, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension(JSH 2014).[J].Hypertens Res,2014,37(4):253-390.
[3] Daskalopoulou SS, Rabi DM, Zarnke KB, et al. The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension[J].Can J Cardiol,2015,31(5):549-568.
[4] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.非ST段抬高急性冠状动脉综合征诊断与治疗指南[J].中华心血管病杂志,2012,40(5):353-367.
[5] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2010,38(8):675-690.
[6] Fihn SD, Gardin JM, Abrams J,et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons[J]. J Am Coll Cardiol,2012,60(24):e44-e164.
[7] No authors listed. The Cardiac Insufficiency Bisoprolol Study Ⅱ(CIBIS-II): a randomised trial[J]. Lancet, 1999, 353(9146):9-13.
[8] No authors listed. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure(MERIT-HF)[J]. Lancet,1999,353(9169):2001-2007.
[9] Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure[J]. N Engl J Med,2001,344(22):1651-1658.

相似文献/References:

[1]张宝丽,许建忠,综述,等.副肾动脉与高血压的研究进展[J].心血管病学进展,2016,(3):224.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.002]
 ZHANG Baoli,XU Jianzhong,TANG Xiaofeng,et al.Accessory Renal Artery and Hypertension[J].Advances in Cardiovascular Diseases,2016,(6):224.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.002]
[2]史敬,综述,马依彤,等.n-3多不饱和脂肪酸对心血管疾病的临床应用[J].心血管病学进展,2016,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
 SHI Jing,MA Yitong.Effects of n-3 Polyunsaturated Fatty Acids on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(6):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
[3]段兴连,综述,常静,等.阻塞性睡眠呼吸暂停低通气综合征及其干预治疗对心血管疾病的临床意义[J].心血管病学进展,2016,(3):289.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.019]
 DUAN Xinglian,CHANG Jing.Clinical Significance of OSAHS and Its Intervention Therapy on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(6):289.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.019]
[4]何平,任洁.C反应蛋白与高血压的关联性研究进展[J].心血管病学进展,2015,(5):596.[doi:10.3969/j.issn.1004-3934.2015.05.018]
 HE Ping,REN Jie.Research Progress of C-Reactive Protein and Hypertension[J].Advances in Cardiovascular Diseases,2015,(6):596.[doi:10.3969/j.issn.1004-3934.2015.05.018]
[5]梅宝菲,孔一慧,李为民.睡眠障碍与心血管疾病研究新进展[J].心血管病学进展,2015,(5):603.[doi:10.3969/j.issn.1004-3934.2015.05.020]
 MEI Baofei,KONG Yihui,LI Weimin.Relationship Between Somnipathy and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2015,(6):603.[doi:10.3969/j.issn.1004-3934.2015.05.020]
[6]成哲,罗素新,夏勇.LCZ696在心血管疾病中的研究进展[J].心血管病学进展,2015,(5):606.[doi:10.3969/j.issn.1004-3934.2015.05.021]
 CHENG Zhe,LUO Suxin,XIA Yong.Research Progress of LCZ696 in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2015,(6):606.[doi:10.3969/j.issn.1004-3934.2015.05.021]
[7]袁静,郭艺芳.利尿剂在降压治疗中的应用[J].心血管病学进展,2015,(6):668.[doi:10.3969/j.issn.1004-3934.2015.06.004]
 YUAN Jing,GUO Yifang.Application of Diuretics in Antihypertensive Treatment[J].Advances in Cardiovascular Diseases,2015,(6):668.[doi:10.3969/j.issn.1004-3934.2015.06.004]
[8]张新军.肾素-血管紧张素系统拮抗剂在高血压治疗中的应用[J].心血管病学进展,2015,(6):673.[doi:10.3969/j.issn.1004-3934.2015.06.005]
 ZHANG Xinjun.Effects of Renin-angiotensin System Antagonists on Treatment of Hypertension[J].Advances in Cardiovascular Diseases,2015,(6):673.[doi:10.3969/j.issn.1004-3934.2015.06.005]
[9]刘茜,黄晶.顽固性高血压的诊断和治疗[J].心血管病学进展,2015,(6):713.[doi:10.3969/j.issn.1004-3934.2015.06.014]
 LIU Xi,HUANG Jing.Diagnosis and Treatment of Resistant Hypertension[J].Advances in Cardiovascular Diseases,2015,(6):713.[doi:10.3969/j.issn.1004-3934.2015.06.014]

备注/Memo

备注/Memo:
作者简介:冯颖青(1965—),主任医师,博士,主要从事高血压临床研究。Email:fyq1819@163.com
更新日期/Last Update: 2016-06-20